AntiCoagulants Market - Forecast(2024 - 2030)

Report Code: HCR 35669 Report Format: PDF + Excel
1. AntiCoagulants Market - Overview
        1.1 Definitions and Scope
2. AntiCoagulants Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. AntiCoagulants Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. AntiCoagulants Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. AntiCoagulants Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. AntiCoagulants Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. AntiCoagulants Market -Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. AntiCoagulants Market - By Drug Class (Market Size -$Million / $Billion)
        8.1 Market Size and Market Share Analysis
        8.2 Application Revenue and Trend Research
        8.3 Product Segment Analysis
            8.3.1 NOACs
            8.3.2 Heparins & LMWH
            8.3.3 Vitamin K Antagonists
            8.3.4 Other Anticoagulant Drugs
9. AntiCoagulants Market - By Route Of Administration (Market Size -$Million / $Billion)
        9.1 Oral Anticoagulants
        9.2 Injectable Anticoagulants
10. AntiCoagulants - By Application (Market Size -$Million / $Billion)
        10.1 Segment type Size and Market Share Analysis
        10.2 Application Revenue and Trends by type of Application
        10.3 Application Segment Analysis by Type
            10.3.1 Atrial Fibrillation & Heart Attack
            10.3.2 Stroke
            10.3.3 Deep Vein Thrombosis (DVT)
            10.3.4 Pulmonary Embolism (PE)
            10.3.5 Others
11. AntiCoagulants- By Geography (Market Size -$Million / $Billion)
        11.1 AntiCoagulants Market - North America Segment Research
        11.2 North America Market Research (Million / $Billion)
            11.2.1 Segment type Size and Market Size Analysis
            11.2.2 Revenue and Trends
            11.2.3 Application Revenue and Trends by type of Application
            11.2.4 Company Revenue and Product Analysis
            11.2.5 North America Product type and Application Market Size
                  11.2.5.1 U.S
                  11.2.5.2 Canada
                  11.2.5.3 Mexico
                  11.2.5.4 Rest of North America
        11.3 AntiCoagulants- South America Segment Research
        11.4 South America Market Research (Market Size -$Million / $Billion)
            11.4.1 Segment type Size and Market Size Analysis
            11.4.2 Revenue and Trends
            11.4.3 Application Revenue and Trends by type of Application
            11.4.4 Company Revenue and Product Analysis
            11.4.5 South America Product type and Application Market Size
                  11.4.5.1 Brazil
                  11.4.5.2 Venezuela
                  11.4.5.3 Argentina
                  11.4.5.4 Ecuador
                  11.4.5.5 Peru
                  11.4.5.6 Colombia
                  11.4.5.7 Costa Rica
                  11.4.5.8 Rest of South America
        11.5 AntiCoagulants- Europe Segment Research
        11.6 Europe Market Research (Market Size -$Million / $Billion)
            11.6.1 Segment type Size and Market Size Analysis
            11.6.2 Revenue and Trends
            11.6.3 Application Revenue and Trends by type of Application
            11.6.4 Company Revenue and Product Analysis
            11.6.5 Europe Segment Product type and Application Market Size
                  11.6.5.1 U.K
                  11.6.5.2 Germany
                  11.6.5.3 Italy
                  11.6.5.4 France
                  11.6.5.5 Netherlands
                  11.6.5.6 Belgium
                  11.6.5.7 Denmark
                  11.6.5.8 Spain
                  11.6.5.9 Rest of Europe
        11.7 AntiCoagulants - APAC Segment Research
        11.8 APAC Market Research (Market Size -$Million / $Billion)
            11.8.1 Segment type Size and Market Size Analysis
            11.8.2 Revenue and Trends
            11.8.3 Application Revenue and Trends by type of Application
            11.8.4 Company Revenue and Product Analysis
            11.8.5 APAC Segment - Product type and Application Market Size
                  11.8.5.1 China
                  11.8.5.2 Australia
                  11.8.5.3 Japan
                  11.8.5.4 South Korea
                  11.8.5.5 India
                  11.8.5.6 Taiwan
                  11.8.5.7 Malaysia
                  11.8.5.8 Hong kong
                  11.8.5.9 Rest of APAC
        11.9 AntiCoagulants - Middle East Segment and Africa Segment Research
        11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            11.10.1 Segment type Size and Market Size Analysis
            11.10.2 Revenue and Trend Analysis
            11.10.3 Application Revenue and Trends by type of Application
            11.10.4 Company Revenue and Product Analysis
            11.10.5 Middle East Segment Product type and Application Market Size
                  11.10.5.1 Israel
                  11.10.5.2 Saudi Arabia
                  11.10.5.3 UAE
            11.10.6 Africa Segment Analysis
                  11.10.6.1 South Africa
                  11.10.6.2 Rest of Middle East & Africa
12. AntiCoagulants Market - Entropy
        12.1 New product launches
        12.2 M&A s, collaborations, JVs and partnerships
13. AntiCoagulants Market - Industry / Segment Competition landscape Premium
        13.1 Market Share Analysis
            13.1.1 Market Share by Country- Top companies
            13.1.2 Market Share by Region- Top 10 companies
            13.1.3 Market Share by type of Application - Top 10 companies
            13.1.4 Market Share by type of Product / Product category- Top 10 companies
            13.1.5 Market Share at global level - Top 10 companies
            13.1.6 Best Practises for companies
14. AntiCoagulants Market - Key Company List by Country Premium
15. AntiCoagulants Market Company Analysis
        15.1 Market Share, Company Revenue, Products, M&A, Developments
        15.2 Abbott Laboratory
        15.3 Astrazeneca
        15.4 Aurobindo Pharma Ltd
        15.5 Biocon
        15.6 Concord Biotech
        15.7 Glaxosmithkline Plc
        15.8 Merck Co Inc
        15.9 Novartis Global
        15.10 Pfizer Inc
        15.11 Sun Pharma
        15.12 Company 12
        15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. AntiCoagulants Market - Appendix
        16.1 Abbreviations
        16.2 Sources
17. AntiCoagulants Market - Methodology
        17.1 Research Methodology
            17.1.1 Company Expert Interviews
            17.1.2 Industry Databases
            17.1.3 Associations
            17.1.4 Company News
            17.1.5 Company Annual Reports
            17.1.6 Application Trends
            17.1.7 New Products and Product database
            17.1.8 Company Transcripts
            17.1.9 R&D Trends
            17.1.10 Key Opinion Leaders Interviews
            17.1.11 Supply and Demand Trends

LIST OF TABLES

1.Global Anticoagulant Market, By Type Market 2023-2030 ($M)
1.1 Betrixaban Market 2023-2030 ($M) - Global Industry Research
1.2 Dabigatran Market 2023-2030 ($M) - Global Industry Research
1.3 Edoxaban Market 2023-2030 ($M) - Global Industry Research
1.4 Rivaroxaban Market 2023-2030 ($M) - Global Industry Research
1.5 Eliquis Market 2023-2030 ($M) - Global Industry Research
2.Global Anticoagulant Market, By Type Market 2023-2030 (Volume/Units)
2.1 Betrixaban Market 2023-2030 (Volume/Units) - Global Industry Research
2.2 Dabigatran Market 2023-2030 (Volume/Units) - Global Industry Research
2.3 Edoxaban Market 2023-2030 (Volume/Units) - Global Industry Research
2.4 Rivaroxaban Market 2023-2030 (Volume/Units) - Global Industry Research
2.5 Eliquis Market 2023-2030 (Volume/Units) - Global Industry Research
3.North America Anticoagulant Market, By Type Market 2023-2030 ($M)
3.1 Betrixaban Market 2023-2030 ($M) - Regional Industry Research
3.2 Dabigatran Market 2023-2030 ($M) - Regional Industry Research
3.3 Edoxaban Market 2023-2030 ($M) - Regional Industry Research
3.4 Rivaroxaban Market 2023-2030 ($M) - Regional Industry Research
3.5 Eliquis Market 2023-2030 ($M) - Regional Industry Research
4.South America Anticoagulant Market, By Type Market 2023-2030 ($M)
4.1 Betrixaban Market 2023-2030 ($M) - Regional Industry Research
4.2 Dabigatran Market 2023-2030 ($M) - Regional Industry Research
4.3 Edoxaban Market 2023-2030 ($M) - Regional Industry Research
4.4 Rivaroxaban Market 2023-2030 ($M) - Regional Industry Research
4.5 Eliquis Market 2023-2030 ($M) - Regional Industry Research
5.Europe Anticoagulant Market, By Type Market 2023-2030 ($M)
5.1 Betrixaban Market 2023-2030 ($M) - Regional Industry Research
5.2 Dabigatran Market 2023-2030 ($M) - Regional Industry Research
5.3 Edoxaban Market 2023-2030 ($M) - Regional Industry Research
5.4 Rivaroxaban Market 2023-2030 ($M) - Regional Industry Research
5.5 Eliquis Market 2023-2030 ($M) - Regional Industry Research
6.APAC Anticoagulant Market, By Type Market 2023-2030 ($M)
6.1 Betrixaban Market 2023-2030 ($M) - Regional Industry Research
6.2 Dabigatran Market 2023-2030 ($M) - Regional Industry Research
6.3 Edoxaban Market 2023-2030 ($M) - Regional Industry Research
6.4 Rivaroxaban Market 2023-2030 ($M) - Regional Industry Research
6.5 Eliquis Market 2023-2030 ($M) - Regional Industry Research
7.MENA Anticoagulant Market, By Type Market 2023-2030 ($M)
7.1 Betrixaban Market 2023-2030 ($M) - Regional Industry Research
7.2 Dabigatran Market 2023-2030 ($M) - Regional Industry Research
7.3 Edoxaban Market 2023-2030 ($M) - Regional Industry Research
7.4 Rivaroxaban Market 2023-2030 ($M) - Regional Industry Research
7.5 Eliquis Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
2.Canada U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
3.Mexico U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
4.Brazil U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
5.Argentina U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
6.Peru U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
7.Colombia U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
8.Chile U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
9.Rest of South America U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
10.UK U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
11.Germany U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
12.France U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
13.Italy U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
14.Spain U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
15.Rest of Europe U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
16.China U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
17.India U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
18.Japan U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
19.South Korea U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
20.South Africa U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
21.North America U.S. AntiCoagulants By Application
22.South America U.S. AntiCoagulants By Application
23.Europe U.S. AntiCoagulants By Application
24.APAC U.S. AntiCoagulants By Application
25.MENA U.S. AntiCoagulants By Application
26.Pfizer Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Astrazeneca, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Novartis Global, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Merck Co Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Biocon, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Glaxosmithkline Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Concord Biotech, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Aurobindo Pharma Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Sun Pharma, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Abbott Laboratory, Sales /Revenue, 2015-2018 ($Mn/$Bn)